|
1
|
Corral DA, Amling M, Priemel M, Loyer E,
Fuchs S, Ducy P, Baron R and Karsenty G: Dissociation between bone
resorption and bone formation in osteopenic transgenic mice. Proc
Natl Acad Sci USA. 95:13835–13840. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Charbord P: Bone marrow mesenchymal stem
cells: Historical overview and concepts. Hum Gene Ther.
21:1045–1056. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sacchetti B, Funari A, Michienzi S, Di
Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG,
Riminucci M and Bianco P: Self-renewing osteoprogenitors in bone
marrow sinusoids can organize a hematopoietic microenvironment.
Cell. 131:324–336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mathews S, Bhonde R, Gupta PK and Totey S:
Extracellular matrix protein mediated regulation of the osteoblast
differentiation of bone marrow derived human mesenchymal stem
cells. Differentiation. 84:185–192. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khosla S, Westendorf JJ and Oursler MJ:
Building bone to reverse osteoporosis and repair fractures. J Clin
Invest. 118:421–428. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghildiyal M and Zamore PD: Small silencing
RNAs: An expanding universe. Nat Rev Genet. 10:94–108. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu T, Zhou H, Hong Y, Li J, Jiang X and
Huang H: miR-30 family members negatively regulate osteoblast
differentiation. J Biol Chem. 287:7503–7511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim KM, Park SJ, Jung SH, Kim EJ, Jogeswar
G, Ajita J, Rhee Y, Kim CH and Lim SK: miR-182 is a negative
regulator of osteoblast proliferation, differentiation, and
skeletogenesis through targeting FoxO1. J Bone Miner Res.
27:1669–1679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Q, Cai J, Cai XH and Chen L: miR-346
regulates osteogenic differentiation of human bone marrow-derived
mesenchymal stem cells by targeting the Wnt/β-catenin pathway. PLoS
One. 8:e722662013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei R, Deng Z and Su J: miR-217 targeting
Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Biomed Pharmacother. 72:158–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng
ZL, He MM, Wang FH, Li YH, Zhang HZ, Pelicano H, et al:
microRNA-217 inhibits tumor progression and metastasis by
downregulating EZH2 and predicts favorable prognosis in gastric
cancer. Oncotarget. 6:10868–10879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM and
Chen J: The miR-217 microRNA functions as a potential tumor
suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
Carcinogenesis. 31:1726–1733. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Zhao J, Zhang JW, Huang QY, Huang
JZ, Chi LS, Tang HJ, Liu GQ, Zhu DJ and Ma WM: MicroRNA-217,
down-regulated in clear cell renal cell carcinoma and associated
with lower survival, suppresses cell proliferation and migration.
Neoplasma. 60:511–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan GZ, Yang Y, Zhang J, Liu W, Wang GY,
Zhang YC, Yang Q, Zhai FX, Tai Y, Liu JR, et al: Bone marrow
mesenchymal stem cells ameliorate hepatic ischemia/reperfusion
injuries via inactivation of the MEK/ERK signaling pathway in rats.
J Surg Res. 178:935–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qu B, Xia X, Wu HH, Tu CQ and Pan XM:
PDGF-regulated miRNA-138 inhibits the osteogenic differentiation of
mesenchymal stem cells. Biochem Biophys Res Commun. 448:241–247.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu L, Liu Y, Hou Y, Wang K, Wong Y, Lin S
and Li G: U0126 promotes osteogenesis of rat bone-marrow-derived
mesenchymal stem cells by activating BMP/Smad signaling pathway.
Cell Tissue Res. 359:537–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krzeszinski JY, Wei W, Huynh H, Jin Z,
Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, et
al: miR-34a blocks osteoporosis and bone metastasis by inhibiting
osteoclastogenesis and Tgif2. Nature. 512:431–435. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garnero P: New developments in biological
markers of bone metabolism in osteoporosis. Bone. 66:46–55. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qadir AS, Um S, Lee H, Baek K, Seo BM, Lee
G, Kim GS, Woo KM, Ryoo HM and Baek JH: miR-124 negatively
regulates osteogenic differentiation and in vivo bone formation of
mesenchymal stem cells. J Cell Biochem. 116:730–742. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huszar JM and Payne CJ: MIR146A inhibits
JMJD3 expression and osteogenic differentiation in human
mesenchymal stem cells. FEBS Lett. 588:1850–1856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang K, Fu J, Zhou W, Li W, Dong S, Yu S,
Hu Z, Wang H and Xie Z: MicroRNA-125b regulates osteogenic
differentiation of mesenchymal stem cells by targeting Cbfβ in
vitro. Biochimie. 102:47–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng Y, Wu S, Zhou H, Bi X, Wang Y, Hu Y,
Gu P and Fan X: Effects of a miR-31, Runx2, and Satb2 regulatory
loop on the osteogenic differentiation of bone mesenchymal stem
cells. Stem Cells Dev. 22:2278–2286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshida CA, Furuichi T, Fujita T, Fukuyama
R, Kanatani N, Kobayashi S, Satake M, Takada K and Komori T:
Core-binding factor beta interacts with Runx2 and is required for
skeletal development. Nat Genet. 32:633–638. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lian JB and Stein GS: Runx2/Cbfa1: A
multifunctional regulator of bone formation. Curr Pharm Des.
9:2677–2685. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai CF, Chaudhary L, Fausto A, Halstead
LR, Ory DS, Avioli LV and Cheng SL: Erk is essential for growth,
differentiation, integrin expression, and cell function in human
osteoblastic cells. J Biol Chem. 276:14443–14450. 2001.PubMed/NCBI
|
|
30
|
Simmons CA, Matlis S, Thornton AJ, Chen S,
Wang CY and Mooney DJ: Cyclic strain enhances matrix mineralization
by adult human mesenchymal stem cells via the extracellular
signal-regulated kinase (ERK1/2) signaling pathway. J Biomech.
36:1087–1096. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao G, Jiang D, Thomas P, Benson MD, Guan
K, Karsenty G and Franceschi RT: MAPK pathways activate and
phosphorylate the osteoblast-specific transcription factor, Cbfa1.
J Biol Chem. 275:4453–4459. 2000. View Article : Google Scholar : PubMed/NCBI
|
